Table 4. Univariate and multivariate logistic regression analysis of comorbidities associated with AKI development.
Variable | OR (unadjusted) | 95% CI | P value | OR (Adjusted)* | 95% CI | P value |
---|---|---|---|---|---|---|
Age (yr) | 1.05 | 1.03–1.07 | <0.001 | - | - | - |
Nationality Bahrain/Non-Bahrain | 3.58 | 2.20–5.85 | <0.001 | 1.50 | 0.85–2.65 | n.s. |
Diabetes | 2.60 | 1.57–4.30 | <0.001 | 2.04 | 1.19–3.50 | <0.01 |
Hypertension | 3.16 | 1.87–5.35 | <0.001 | 2.04 | 1.16–3.61 | <0.05 |
Cardiovascular Disease | 2.25 | 1.04–4.89 | <0.05 | 1.73 | 0.76–3.92 | n.s. |
Chronic Pulmonary Disease | 0.70 | 0.28–1.76 | n.s | 0.53 | 0.20–1.40 | n.s. |
Any 1 Comorbidity | 2.98 | 1.63–5.44 | <0.001 | 1.90 | 0.99–3.67 | n.s. |
Any 2 Comorbidity | 5.76 | 2.99–11.10 | <0.001 | 2.56 | 1.24–5.30 | <0.05 |
Any 3 or more Comorbidity | 14.62 | 7.16–29.82 | <0.001 | 5.70 | 2.59–12.52 | <0.001 |
*Adjusted for age.